糖尿病治疗药物(Diabetes treatment drugs).docVIP

糖尿病治疗药物(Diabetes treatment drugs).doc

  1. 1、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
糖尿病治疗药物(Diabetes treatment drugs)

糖尿病治疗药物(Diabetes treatment drugs) Clinical application of oral antidiabetic drugs Abstract Objective: to reveal the research progress of oral antidiabetic drugs and to promote its rational use in clinic. Methods: the literatures about oral treatment of type 2 diabetes mellitus in China were analyzed and summarized in recent 3 years. Results: the clinical use of oral anti diabetic drugs with metformin as the drug of choice for most patients with newly diagnosed diabetes, combined with patients and health status, to choose the application of sulfonylurea, # glucosidase inhibitor, thiazolidine ketone, two non sulfonylurea antidiabetic drug (glinides), this 5 kinds of basic drugs for the treatment of type 2 diabetes, and another two dipeptidyl peptidase inhibitor clinical data is less. Conclusion: Patients with diabetes should be rational drug selection according to their own situation, must be on time and quality, adhere to medication, and regularly check the blood sugar, blood ester, liver and kidney function, HbA1c index, in order to instantly adjust drug varieties and dosage, minimize adverse reactions, improve the life quality of patients with diabetes mellitus. Keywords oral antidiabetic drugs; rational use; IDF report from 2010-2030 patients with diabetes worldwide the number will increase from 285 million to 439 million, and in patients with impaired glucose tolerance will increase from 344 million to 472 million [1] this shows that by 2030, the world will have 900 million people suffering from diabetes or diabetes in high-risk status, they risk suffering from cardiovascular disease increased 2-3 times. At present, as the global an epidemic of diabetes on health, social and economic had a devastating impact. Diabetes is a metabolic disease caused by various causes, which is caused by defects in insulin secretion and / or insulin defect caused by chronic hyperglycemia, and carbohydrate, fat and protein metabolism disorders. Its chronic complications mainly includ

文档评论(0)

f8r9t5c + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:8000054077000003

1亿VIP精品文档

相关文档